Regulation of Angiogenic Factors by HDM2 in Renal Cell Carcinoma

Cancer Research - United States
doi 10.1158/0008-5472.can-06-4738
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Prognostic Factors in Patients With Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1999English

Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2016English

Down-Regulation of PKCζ in Renal Cell Carcinoma and Its Clinicopathological Implications

Journal of Biomedical Science
Cell BiologyPharmacologyBiochemistryEndocrinologyClinical BiochemistryMolecular BiologyMedicineMetabolismDiabetes
2012English

Neutrophils From Renal Cell Carcinoma Patients Show Increased Expression of Immunosuppressive and Angiogenic Gene Profile

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Renal Cell Carcinoma: Review of Etiology, Pathophysiology and Risk Factors

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
BiochemistryMedicineGeneticsMolecular Biology
2016English

Risk Factors for Brain Metastases in Patients With Renal Cell Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Down-Regulation of TCF21 Is Associated With Poor Survival in Clear Cell Renal Cell Carcinoma

Neoplasma
Cancer Research
2012English

Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial

Oncologist
Cancer ResearchMedicineOncology
2015English

Renal Cell Carcinoma

World Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy